These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 3414860

  • 21. Cocaine-induced cocaine craving.
    Jaffe JH, Cascella NG, Kumor KM, Sherer MA.
    Psychopharmacology (Berl); 1989; 97(1):59-64. PubMed ID: 2496428
    [Abstract] [Full Text] [Related]

  • 22. Use of a cue exposure paradigm for the evaluation of a potential pharmacotherapeutic agents for cocaine dependence.
    Kranzler HR, Bauer LO.
    Addict Behav; 1993; 18(6):599-60. PubMed ID: 8178699
    [No Abstract] [Full Text] [Related]

  • 23. Medications development at the National Institute on Drug Abuse: focus on cocaine.
    Johnson DN, Vocci FJ.
    NIDA Res Monogr; 1993; 135():57-70. PubMed ID: 8289904
    [Abstract] [Full Text] [Related]

  • 24. Bromocriptine abuse.
    Ross RG, Ward NG.
    Biol Psychiatry; 1992 Feb 15; 31(4):404-6. PubMed ID: 1558903
    [No Abstract] [Full Text] [Related]

  • 25. Central stimulant abuse: neurochemistry and pharmacotherapy.
    Dackis CA, Gold MS, Pottash AL.
    Adv Alcohol Subst Abuse; 1986 Feb 15; 6(2):7-21. PubMed ID: 2886014
    [Abstract] [Full Text] [Related]

  • 26. Bromocriptine for cocaine dependence. A controlled clinical trial.
    Handelsman L, Rosenblum A, Palij M, Magura S, Foote J, Lovejoy M, Stimmel B.
    Am J Addict; 1997 Feb 15; 6(1):54-64. PubMed ID: 9097872
    [Abstract] [Full Text] [Related]

  • 27. Bromocriptine antagonizes behavioral effects of cocaine in the rat.
    Campbell A, Baldessarini RJ, Cremens C, Teicher MH, Marsh E, Kula NS.
    Neuropsychopharmacology; 1989 Sep 15; 2(3):209-24. PubMed ID: 2789660
    [Abstract] [Full Text] [Related]

  • 28. [Bromocriptine: uses until now and prospects of new therapeutic applications].
    Górska D.
    Neurol Neurochir Pol; 2000 Sep 15; 34(3):573-8. PubMed ID: 10979549
    [Abstract] [Full Text] [Related]

  • 29. Bromocriptine for cocaine users.
    Friedman EH.
    J Gen Intern Med; 1993 Jun 15; 8(6):344. PubMed ID: 8320581
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers.
    Preston KL, Sullivan JT, Strain EC, Bigelow GE.
    NIDA Res Monogr; 1990 Jun 15; 105():507. PubMed ID: 1876101
    [No Abstract] [Full Text] [Related]

  • 32. Effects of bromocriptine pretreatment on subjective and physiological responses to i.v. cocaine.
    Kumor K, Sherer M, Jaffe J.
    Pharmacol Biochem Behav; 1989 Aug 15; 33(4):829-37. PubMed ID: 2616602
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pergolide mesylate treatment of cocaine withdrawal.
    Malcolm R, Hutto BR, Phillips JD, Ballenger JC.
    J Clin Psychiatry; 1991 Jan 15; 52(1):39-40. PubMed ID: 1988417
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A pilot trial of amantadine for ambulatory withdrawal for cocaine dependence.
    Morgan C, Kosten T, Gawin F, Kleber H.
    NIDA Res Monogr; 1988 Jan 15; 81():81-5. PubMed ID: 3136395
    [No Abstract] [Full Text] [Related]

  • 39. Amantadine in the treatment of cocaine withdrawal.
    Thompson DF.
    Ann Pharmacother; 1992 Jan 15; 26(7-8):933-4. PubMed ID: 1504406
    [No Abstract] [Full Text] [Related]

  • 40. Serum prolactin levels during extended cocaine abstinence.
    Swartz CM, Breen K, Leone F.
    Am J Psychiatry; 1990 Jun 15; 147(6):777-9. PubMed ID: 2343924
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.